Johnson & Johnson files application to conduct study on its COVID vaccine in adolescents

By: |
August 20, 2021 3:53 PM

The US-based pharmaceutical company noted that it is committed to facilitating global equitable access to its COVID-19 vaccine and recognise the unmet needs of children.

Johnson and Johnson's single-dose Covid-19 vaccine is given approval for Emergency Use in India," health minister Mansukh Mandaviya tweeted on Saturday.Earlier this month, the government had given Emergency Use approval to J&J's single-dose COVID-19 vaccine in India

Johnson & Johnson (J&J) on Friday said it has submitted an application to the Indian drug regulator to conduct a study of its COVID-19 vaccine in adolescents aged 12-17 years.

The US-based pharmaceutical company noted that it is committed to facilitating global equitable access to its COVID-19 vaccine and recognise the unmet needs of children.

“On August 17, 2021, we submitted an application to the Central Drugs Standard Control Organisation (CDSCO) to conduct a study of the Johnson & Johnson COVID-19 vaccine in India in adolescents aged 12-17 years,” a J&J India spokesperson said in a statement.

To ultimately achieve herd immunity, it is imperative that COVID-19 vaccine clinical trials continue to move forward in this population, the spokesperson added.

“We remain deeply committed to the critical work needed to make our COVID-19 vaccine equitably accessible for all age groups,” the company spokesperson noted.

Earlier this month, the government had given Emergency Use approval to J&J’s single-dose COVID-19 vaccine in India.

While announcing the approval, Union Health Minister Mansukh Mandaviya had said the approval would further boost the country’s collective fight against the novel coronavirus infection.

The five vaccines granted Emergency Use Authorisation in India are Serum Institute’s Covishield, Bharat Biotech’s Covaxin, Russia’s Sputnik V, Moderna and J&J.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Novavax, Serum seek emergency use approval from WHO for Covid vaccine
2ICMR says no to use of Hydroxycholoroquine, Ivermectin for Covid
3India’s COVID-19 vaccination figure crosses 84.42 cr doses